Portal de Periódicos da CAPES

Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy?

2006; Wiley; Volume: 95; Issue: 8 Linguagem: Inglês

10.1002/jso.20708

1096-9098

Melvin J. Silverstein, Michael D. Lagios,

Global Cancer Incidence and Screening

Journal of Surgical OncologyVolume 95, Issue 8 p. 605-609 Guest Editorial Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? No: One size does not fit all: An argument against the routine use of radiation therapy for all patients with ductal carcinoma in situ of the breast who elect breast conservation Melvin J. Silverstein MD, Corresponding Author Melvin J. Silverstein MD [email protected] Keck School of Medicine, University of Southern California, Los Angeles, California Professor of Surgery and Henrietta C. Lee Chair in Breast Cancer Research.1441 East Lake Avenue, Room 7415, Los Angeles, California, United States 90033. Fax: (323) 865-3539.Search for more papers by this authorMichael D. Lagios MD, Michael D. Lagios MD Breast Consultation Service, Tiburon, CaliforniaSearch for more papers by this author Melvin J. Silverstein MD, Corresponding Author Melvin J. Silverstein MD [email protected] Keck School of Medicine, University of Southern California, Los Angeles, California Professor of Surgery and Henrietta C. Lee Chair in Breast Cancer Research.1441 East Lake Avenue, Room 7415, Los Angeles, California, United States 90033. Fax: (323) 865-3539.Search for more papers by this authorMichael D. Lagios MD, Michael D. Lagios MD Breast Consultation Service, Tiburon, CaliforniaSearch for more papers by this author First published: 27 December 2006 https://doi.org/10.1002/jso.20708Citations: 23 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Bijker N, Meijnen P, Peterse J, et al.: Breast conserving treatment with or without radiotherapy in ductal carcinoma in situ: Ten-year results of European organization for research and treatment of cancer randomized phase III trial 10853—A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006; 24: 1–8. 2 UK Coordinating Committee on Cancer Research (UKCCCR): Ductal Carcinoma in Situ (DCIS) working party, radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003; 362: 95–102. 3 Fisher B, Land S, Mamounas E, et al.: Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project Experience. Semin Oncol 2001; 28: 400–418. 4 Sposto R, Epstein M, Silverstein MJ: Predicting local recurrence in patients with ductal carcinoma in situ of the breast. In: MJ Silverstein, A Recht, M Lagios, editors. Ductal carcinoma in situ of the breast, Philadelphia: Lippincott, Williams and Wilkins; 2002, 255–263. 5 Bijker N, Peterse J, Duchateau L, et al.: Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in situ: Analysis of European organization for research and treatment of cancer trial 10853. J Clin Oncol 2001; 19: 2263–2271. 6 Fisher B, Costantino J, Redmond C, et al.: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993; 328: 1581–1586. 7 Silverstein MJ, Buchanan C: Ductal carcinoma in situ: USC/Van nuys prognostic index and the impact of margin status. The Breast 2003; 12: 457–471. 8 Silverstein MJ: The University of Southern California/Van nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 2003; 186: 337–343. 9 Silverstein MJ: An argument against routine use of radiotherapy for ductal carcinoma in situ. Oncology 2003; 17: 1511–1546. 10 Romero L, Klein L, Ye W, et al.: Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast. Am J Surg 2004; 188: 371–376. 11 Silverstein MJ, Lagios M, Martino S, et al.: Outcome after local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol 1998; 16: 1367–1373. 12 Surveillance Epidemiology and End Results (SEER) Program: P-ud-NCI, DCCPS Surveillance Research Program, Cancer Statistics Branch. www.seer.cancer.gov (released April 2004), Public use data. 2004. 13 Early Breast Cancer Trialists' Collaborative Group: Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer. Lancet 2000; 355: 1757–1770. 14 Holland R, Faverly D: Whole organ studies. Ductal carcinoma in situ of the breast, M Silverstein, editor. Baltimore: Williams and Wilkins; 1997, 233–240. 15 Holland R, Faverly D: Whole organ studies, in ductal carcinoma in situ of the breast, MJ Silverstein, A Recht, M Lagios, editors. Philadelphia: Lippincott, Williams and Wilkins; 2002, pp 240–254. 16 Holland R, Hendriks J, Verbeek A, et al.: Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990; 335: 519–522. 17 Holland R, Hendriks J: Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diag Pathol 1994; 11: 181–192. 18 Holland R, Peterse J, Millis R, et al.: Ductal carcinoma in situ: A proposal for a new classification. Semin Diag Pathol 1994; 11: 167–180. 19 Faverly D, Burgers L, Bult P, et al.: Three dimensional imaging of mammary ductal carcinoma is situ: Clinical implications. Semin in Diag Pathol 1994; 11: 193–198. 20 Page D, Dupont W, Roger L, et al.: Intraductal carcinoma of the breast: Follow-up after biopsy only. Cancer 1982; 49: 751–758. 21 Page D, Dupont W, Roger L, et al.: Atypical hyperplastic lesions of the female breast. A log-term follow-up study. Cancer 1985; 55: 2698–2708. 22 Page D, Dupont W, Rogers L, et al.: Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995; 76: 1197–1200. 23 Lagios M: Controversies in diagnosis, biology, and treatment. Breast J 1995; 1: 68–78. 24 Page D, Rogers L, Schuyler P, et al.: The natural history of ductal carcinoma in situ of the breast, In MJ Silverstein, A Recht, M Lagios, editors. Ductal carcinoma in situ of the breast, Philadelphia: Lippincott, Williams and Wilkins; 2002, 17–21. 25 Sanders M, Schuyler P, Dupont W, et al.: The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 2005; 103: 2481–2484. 26 Group, EBCTC: Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials. Lancet 2006; 2000: 1757–1770. 27 Giordano S, Kuo Y, Freeman J, et al.: Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005; 97: 419–424. 28 Darby S, McGale P, Taylor C, et al.: Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women un US SEER cancer registries. Lancet Oncol 2005; 6: 557–565. 29 Zablotska L, Neugut A: Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer 2003; 97: 1404–1411. 30 Darby S, McGale P, Peto R, et al.: Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: Nationwide cohort study of 90,000 Swedish women. BMJ 2003; 326: 256–257. 31 Wong J, Kaelin C, Troyan S, et al.: Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 2006; 24: 1031–1036. 32 Lagios M, Page D, Silverstein M: Prospective study of wide excision alone for ductal carcinoma in situ of the breast [comment]. J Clin Oncol 2006; 24: 3809–8811. 33 Silverstein MJ, Waisman J: Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. In: MJ Silverstein, A Recht, M Lagios, editors. Ductal carcinoma in situ of the breast. Philadelphia: Lippincott, Williams and Wilkins; 2002, 545–553. 34 Schwartz G: Treatment of subclinical ductal carcinoma in situ of the breast by local excision and surveillance: An updated personal experience. In: MJ Silverstein, A Recht, M Lagios, editors. Ductal carcinoma in situ of the breast. Philadelphia: Lippincott, Williams and Wilkins; 2002, 308–321. Citing Literature Volume95, Issue815 June 2007Pages 605-609 ReferencesRelatedInformation